Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of...
Reexamination Certificate
2008-03-11
2008-03-11
Qian, Celine (Department: 1636)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
C435S007220, C435S335000, C435S339000, C435S372000, C435S375000
Reexamination Certificate
active
07341870
ABSTRACT:
The invention relates to plasmacytoid dendritic human cell lines and methods for producing the cell lines. More specifically, the invention relates to the plasmacytoid dendritic human cell line called GEN2.2, which is deposited in the CNCM under number CNCM 1-2938 and the plasmacytoid dendritic human cell line called GEN3, which is deposited in the CNCM under number I-3110. The use of cells from the cell lines is also disclosed.
REFERENCES:
patent: 5648219 (1997-07-01), MacKay et al.
patent: 7038029 (2006-05-01), Lopez
patent: 2003/0148316 (2003-08-01), Lipford et al.
patent: 2004/0006032 (2004-01-01), Lopez
patent: WO 02/40646 (2002-05-01), None
patent: WO 02/40647 (2002-05-01), None
Decker WK, Xing D, Shpall EJ. Dendritic cell immunotherapy for the treatment of neoplastic disease. Biol Blood Marrow Transplant. Feb. 20096;12(2):113-25. Review. □□
Laurence Chaperot et al., “Identification of a leukemic counterpart of the plasmacytoid dendritic cells”, 2001 by The American Society of Hematology, Blood, May 15, 2001, vol. 97, No. 10, pp. 3210-3217.
Andrzej Dzionek et al., “Plasmacytoid Dendritic Cells: From Specific Surface Markers to Specific Cellular Functions”, American Society for Histocompatibility and Immunogenetics, 2002 Published by Elsevier Science Inc. Human Immunology 63, pp. 1133-1148 (2002).
Marina Cella et al., “Plasmacytoid monocytes migrate to inflammed lymph nodes and produce large amounts of type I interferon”, Aug. 1999, 919-923, vol. 5, No. 8.
Jacques Banchereau et al., “Immunobiology of Dendritic Cells”, Annu. Rev. Immunol. 2000., 18: pp. 767-811.
Ralph M. Steinman et al., “Exploiting dendritic cells to improve vaccine efficacy”, The Journal of Clinical Investigation, Jun. 2002, vol. 109, No. 12, pp. 1519-1526.
Chaperot-Dubonnet Laurence
Plumas Joel
Etablissement Francais du Sang
Mitchell Laura M
Oliff & Berridg,e PLC
Qian Celine
LandOfFree
Dendritic cell line does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dendritic cell line, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dendritic cell line will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2790306